Abstract Purpose Many physicians recommend mastectomy in case of multifocal (MF) or multicentric (MC) breast cancer due to a theoretical risk of poor local control with less extensive surgery. We retrospectively evaluate outcome of patients with MF/MC cancers who had breast conservation with specific attention on local control and predictive factors of recurrence. Patients and methods Four hundred and seventy six patients with either MF (n = 421) or MC (n = 55) breast cancer, underwent breast-conserving surgery between 1997 and 2002 in a single institution. Median follow up was 73 months (range 11-118). Results Median age was 53 years (range 23-86). Invasive lobular carcinoma was found in 88 patients (18.5%) and mixed ductal-lobular cancer in 27 (5.7%) patients. Two hundred and sixty-seven patients (76.7%) had two identified tumor foci, 55 patients (15.3%) had three and 29 patients (8.0%) had four or more. Two hundred and sixty-one patients (55.3%) had nodal involvement. The 5-year cumulative incidence of local relapse was 5.1%. At the multivariate analysis, over-expression of HER2/neu and lack of both estrogen and progesterone receptors (HR: 3.2, 95% C.I.
Introduction
With widespread use of mammographic screening and increased accuracy of diagnostic imaging, the surgical treatment of multifocal (MF) and multicentric (MC) breast cancer has come to represent a new challenge for the conservative approach [1] . The presence of multiple foci of cancer within the same breast has traditionally been considered a contraindication for conservative surgery. In fact, many surgeons continue to propose mastectomy for MF/ MC because earlier series have demonstrated high rates of local recurrence following breast conserving surgery [2, 3] . Moreover, physicians often recommend mastectomy in order to complete local treatment when unexpected multifocality is documented at the final pathologic report, even when surgical margins are disease-free. When two separate tumours are located in different quadrants, breast conservation is not usually considered even in patients with large breasts who might be suitable for a double wide excision. However, the difficulty of endorsing a conservative approach in these patients could be explained by limited available data.
The aim of this study was to retrospectively evaluate the outcome of patients with multiple invasive breast cancer who received conservative surgery with special attention being paid to local control, and to identify predictive factors for recurrence in these patients.
Patients and methods
Between March 1997 and December 2002, 8100 patients were operated on for invasive breast cancer at the European Institute of Oncology of Milan, Italy and were prospectively entered into our data base. We retrieved 476 patients who underwent conservative surgery for MF or MC breast cancer (at least two different pathologically confirmed invasive foci within the same breast). Diagnosis of multiple invasive breast cancer was performed either clinically by palpation, radiologically or at pathological examination. Multifocality was defined as the presence of different tumours within the same quadrant, and multicentricity as the presence of tumours in different quadrants of the breast, which were managed by a double incision.
All patients' cases were discussed after surgery at a multidisciplinary meeting attended by breast surgery, medical oncology, radiotherapy and pathology specialists. Sixty patients (12.6%) received adjuvant chemotherapy alone, 191 patients (40.1%) received hormonal therapy alone, and 217 (45.6%) patients received both chemotherapy and endocrine treatment. Eight patients (1.7%) did not receive any medical adjuvant treatment.
Four-hundred and fifty-four patients received standard postoperative external whole breast radiotherapy, 13 received intra-operative radiotherapy and nine did not receive any radiation treatment. The median age was 53 years (range 23-86). The median follow up was 73 months (range 11-118).
Two-hundred and seventy eight patients underwent upfront axillary dissection either due to the presence of clinically pathological nodes or because they had been treated before the sentinel node era. Eighty-eight underwent sentinel lymph node biopsy (SLNB) and axillary dissection because of the presence of metastases in the sentinel node, 106 received SLNB alone, and four did not have any axillary staging.
All those patients who were not seen in the last 6 months were contacted by telephone in order to update the follow up. No patients were lost to follow up.
Pathology
The distinction between the tumors was assessed both grossly, recording the distance between the foci and microscopically, routinely sampling the interposed tissue between the neoplastic foci. Multifocality and multicentricity were prospectively diagnosed on the pathology report only if the interposed tissue was free of neoplasia, both in situ or infiltrating.
HER-2/neu over-expression was investigated immunohistochemically, using a specific polyclonal antiserum (Dako A/S, Carpinteria, CA). The staining results were recorded in a four-tier scale, from 0 to 3+, according to the percentage of immunoreactive cells, and to the intensity and completeness of membrane staining as recommendend by the Food and Drug Administration, USA [4] . Only an intense and complete membrane staining of the tumour cells (3+) was taken as evidence of Her2/neu over-expression.
Patients with distant metastases, bilateral cancer, clinical or pathological T4 or those who received primary medical treatment were excluded from the analysis. Table 1 summarizes the patients' and tumours' characteristics. The reported tumor size represents the largest tumor focus. Ten patients had focally positive margins at the final pathologic report and, after careful discussion of the available options, were not submitted to re-excision according to patient' preference.
Statistical considerations
Primary endpoints were cumulative incidence of local events, cumulative incidence of first events and cumulative mortality. Recurrences within the same breast, with or without involvement of regional nodes, were considered as local events. First events were any type of recurrence, second primary cancer, contralateral breast cancer recurrence or death, whichever occurred first. If patients had simultaneous local and distant recurrence they were considered as having a distant recurrence in the analysis. Cumulative mortality was calculated as the cumulative incidence of deaths from any cause.
Crude cumulative incidence of local events was computed in a competing risk framework as described by Marubini and Valsecchi [5] , and compared across different subgroups by means of the Gray test [6] . The Log-rank test was used to assess survival differences between groups for cumulative incidence of first events and cumulative mortality. Multivariate Cox proportional hazards regression models were used to identify the prognostic independent clinico-pathological features associated with survival. For local events, Cox Proportional Hazard model was computed in a competing risk framework [7] . All analyses were performed with the SAS software (SAS Institute, Cary, NC) and the R software (The R Development Core Team 2004; Free Software Foundation, Boston, MA). All tests were two-sided. Table 2 describes the events. Briefly, 24 patients (5.0%) developed ipsilateral breast recurrence, 2 (0.4%) had locoregional recurrence, and 51 (10.7%) had distant metastases as first event.
Figures 1 and 2 represent cumulative incidence of local recurrence (5.1% at 5 years) and mortality (6.2% at 5 years), respectively.
Factors related to local and distant relapses, and to overall survival at the univariate and multivariate analyses are listed in Tables 3 and 4 , respectively.
At the multivariate analysis, over-expression of HER2/ neu and lack of both estrogen and progesterone receptors (HR: 3.2, 95% C.I. 1.01-10.0, and HR: 2.7, 95% C.I. 1.06-7.7, respectively) were associated with higher ipsilateral breast cancer reappearance rate. Involvement of 4 or more lymph nodes and lack of estrogen and progesterone receptors (HR: 2.7, 95% C.I. 1.06-6.7, and HR: 4.7, 95% C.I. 2.1-10.4, respectively) were associated with poorer overall survival.
Discussion
To our knowledge, few papers [2, 3, [8] [9] [10] [11] [12] [13] have been published concerning conservative surgery in patients with MF/MC, and all have dealt with a limited number of patients. Former series reported a high risk of local recurrence in patients treated with conservative surgery. In fact, Kurtz et al. [2] in their experience with 61 patients with two or more macroscopic tumor nodules, concluded that patients with macroscopically multiple invasive breast cancer were at a higher risk of local failure if tumors were clinically or radiologically apparent (36% rate of local recurrence). Wilson and colleagues [3] reported that the local recurrence rate was greater in patients with synchronous ipsilateral breast cancer as compared to patients with single lesions (72-month actuarial breast recurrence rate of 25% and 12%, respectively). More recently, Cho et al. [11] reported that in selected cases the combination of conservative surgery and radiation therapy resulted in acceptable local-regional control, based on their experience with 15 patients affected by multiple ipsilateral invasive breast cancer. Kaplan et al. [12] , after evaluating their experience with 36 patients, concluded that breast conservation is an effective treatment for patients with synchronous ipsilateral breast carcinoma. Okumura and colleagues [13] compared 34 patients with multiple invasive breast cancer to 594 patients with unifocal disease and confidence interval bands were computed in a competing risk framework. did not find any difference in terms of local control, disease-free survival or cosmetic result. Our attitude is strongly in favour of breast conservation, and we elect this surgical approach as the treatment of choice, even for patients with multiple invasive cancer as long as it is technically and cosmetically feasible. Here, we re-evaluate the largest series of patients with pathologically confirmed multiple foci of breast cancer and treated with breast conservation. Our cohort comprises patients with multiple palpable tumours located within the same quadrant or in different quadrants, or patients with an unexpected MF invasive disease found at the final pathological report. Multifocalilty and multicentricity in breast cancer are historically defined as the presence of two or more tumor foci within a single quadrant of the breast or within different quadrants of the same breast, respectively [14] . The only significant difference between patients with MF and MC tumours was the number of foci, which was higher in patients with MC disease. In our opinion, these definitions help to simply illustrate two different scenarios of multiple invasive breast cancer. As two separate tumors within the same quadrant could in fact be more distant from each other than two tumors located in different quadrants, it is important to point out that strict definitions run the risk of falling into discussions which are merely semantic. The distance between tumors should also be regarded with caution, as overall proportion with breast size should be also taken into account. It is interesting to note that despite the high rate of node metastases (55% of the patients), as expected in MF/MC breast cancer [15, 16] , distant metastases occurred in only 10.7% of the patients. One might speculate that the high rate of endocrine-responsive tumours in this series (87.6%), which is probably related to the high prevalence of invasive lobular carcinomas, might lead to a better outcome following adequate adjuvant treatment at least during the first 5 years. Furthermore, patients with lobular or ductal carcinoma had a similar outcome in terms of local recurrence (4.4 and 6.1%, respectively). This confirms that, despite the common multifocality and bilaterality of invasive lobular carcinoma, its occurrence does not by itself preclude breast conservation, as long as it is adequately excised.
Fig. 1 Cumulative incidence of local events
The main finding of our study is that the 5 years cumulative incidence of local relapse was 5.1%, which is in our opinion quite acceptable and similar to that reported in patients with unifocal disease [17, 18] . Therefore, these data, derived from a large series of patients, emphasize that breast conserving surgery is safe for patients with MF/MC breast cancer, as it provides acceptable local control when the disease is adequately excised. Furthermore, breast conservation achieved a good outcome even in patients with MC disease who were treated with separate wide local excisions (8% 5 years cumulative incidence of local relapse).
The multivariate analysis which showed that over-expression of HER2/neu and lack of estrogen and progesterone receptors worsened local disease free survival. Due to the availability of an effective therapy against cells over-expressing HER2/neu it is likely that outcome will be improved with the adjuvant administration of trastuzumab [19, 20] . This is a retrospective analysis and therefore some limitations have to be underlined. First, we were not able to collect reliable data on clinical and radiological presentation. It would be interesting to have this information in order to better characterize the patient cohort. Obviously, all patients with multicentric cancer had preoperative diagnosis since they underwent double incision but for the majority of the population we cannot say how many patients had either clinically palpable lumps or radiologically detected tumours or incidental finding at surgery or at pathologic evaluation. Secondly, this is a selected population of patients. In fact, all these women were considered suitable for breast conservation from both the oncologic and cosmetic point of view after careful discussion.
Despite the above mentioned limitations and critiques which might be raised, we think that these data are of important clinical interest since only a few papers with a limited number of patients have been reported so far on this topic. In specialized centers with high patient volume conservative surgery is usually performed in presence of multifocal cancer, but many surgeons or medical oncologists acting in community hospitals continue to recommend mastectomy for the presence of multifocality itself.
As stated earlier, patients were selected for the expected acceptable cosmetic outcome as well. In most cases of multicentric cancer women had large breasts with tumors far each other and located at the periphery of the breast. In this clinical scenario it is not hard to imagine that satisfactory outcome could be achieved. We believe that the data collected within this study are relevant to the discussion with motivated patients in order to decide upon the type of surgery to be conducted. Given the low rate of local recurrence, in selected patients breast conservation can be considered for patients with MF/MC breast cancer, whenever adequate surgery and acceptable cosmetic results can be achieved.
